Guidelines for the use of palivizumab in infants and young children with congenital heart disease

Pediatr Int. 2006 Apr;48(2):190-3. doi: 10.1111/j.1442-200X.2006.02179.x.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use*
  • Child, Preschool
  • Comorbidity
  • Drug Interactions
  • Heart Defects, Congenital / epidemiology*
  • Humans
  • Infant
  • Palivizumab
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Respiratory Syncytial Virus Infections / epidemiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Palivizumab